Use of iPSC-Derived Smooth Muscle Cells to Model Physiology and Pathology
Arteriosclerosis, Thrombosis, and Vascular Biology · 2024-07 · 44 (7) · 1523-1536
DOI: 10.1161/atvbaha.123.319703 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024-07. Verfasst von Callie S Kwartler und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Genetics, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, TX. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Myocytes, Smooth Muscle, Cell Differentiation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
The implementation of human induced pluripotent stem cell (hiPSC) models has introduced an additional tool for identifying molecular mechanisms of disease that complement animal models. Patient-derived or CRISPR/Cas9-edited induced pluripotent stem cells differentiated into smooth muscle cells (SMCs) have been leveraged to discover novel mechanisms, screen potential therapeutic strategies, and model in vivo development. The field has evolved over almost 15 years of research using hiPSC-SMCs and has made significant strides toward overcoming initial challenges such as the lineage specificity of SMC phenotypes. However, challenges both specific (eg, the lack of specific markers to thoroughly validate hiPSC-SMCs) and general (eg, a lack of transparency and consensus around methodology in the field) remain. In this review, we highlight the recent successes and remaining challenges of the hiPSC-SMC model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Genetics, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, TX.
ORCID-Profile: Jose Emiliano Esparza Pinelo
Förderung
- NCATS NIH HHS
Zitieren
APA
Kwartler, C. S., & Esparza Pinelo, J. E. (2024). Use of iPSC-Derived Smooth Muscle Cells to Model Physiology and Pathology. Arteriosclerosis, Thrombosis, and Vascular Biology, 44(7), 1523-1536. https://doi.org/10.1161/atvbaha.123.319703
Vancouver
Kwartler CS, Esparza Pinelo JE. Use of iPSC-Derived Smooth Muscle Cells to Model Physiology and Pathology. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024;44(7):1523-1536. doi:10.1161/atvbaha.123.319703
BibTeX
@article{Kwartler2024,
author = {Kwartler, Callie S and Esparza Pinelo, Jose Emiliano},
title = {Use of iPSC-Derived Smooth Muscle Cells to Model Physiology and Pathology},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2024},
volume = {44},
number = {7},
pages = {1523--1536},
doi = {10.1161/atvbaha.123.319703}
}
EUVIMED